106 related articles for article (PubMed ID: 26025112)
1. Letter regarding Xiao WZ et al. entitled "Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis".
Dai W; Chen J; Guo X; Su Z
Tumour Biol; 2015 Jun; 36(6):4089. PubMed ID: 26025112
[TBL] [Abstract][Full Text] [Related]
2. Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis.
Xiao WZ; Han DH; Wang F; Wang YQ; Zhu YH; Wu YF; Liu NT; Sun JY
Tumour Biol; 2014 Jul; 35(7):6687-93. PubMed ID: 24705863
[TBL] [Abstract][Full Text] [Related]
3. Mutations of PTEN gene in gliomas correlate to tumor differentiation and short-term survival rate.
Yang Y; Shao N; Luo G; Li L; Zheng L; Nilsson-Ehle P; Xu N
Anticancer Res; 2010 Mar; 30(3):981-5. PubMed ID: 20393024
[TBL] [Abstract][Full Text] [Related]
4. Exosomal PTEN as a Predictive Marker of Aggressive Gliomas.
Patnam S; Samal R; Koyyada R; Joshi P; Singh AD; Nagalla B; Soma MR; Sannareddy RR; Ippili K; Raju S; Boola RG; Lath R; Ranjan A; Ghosh S; Balamurugan M; Ray A; Manda SV
Neurol India; 2022; 70(1):215-222. PubMed ID: 35263886
[TBL] [Abstract][Full Text] [Related]
5. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
6. Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia.
Abdullah JM; Farizan A; Asmarina K; Zainuddin N; Ghazali MM; Jaafar H; Isa MN; Naing NN
Asian J Surg; 2006 Oct; 29(4):274-82. PubMed ID: 17098662
[TBL] [Abstract][Full Text] [Related]
7. The role of the PTEN gene in malignant gliomas.
Alexiou GA; Voulgaris S
Neurol Neurochir Pol; 2010; 44(1):80-6. PubMed ID: 20358487
[TBL] [Abstract][Full Text] [Related]
8. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
Zainuddin N; Jaafar H; Isa MN; Abdullah JM
Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579
[TBL] [Abstract][Full Text] [Related]
9. Malignant glioma: the involvement of loss of allelic heterozygosity and PTEN mutations in a group of Malay patients.
Zainuddin N; Jaafar H; Isa MN; Abdullah JM
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):748-56. PubMed ID: 16124450
[TBL] [Abstract][Full Text] [Related]
10. PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis.
Han F; Hu R; Yang H; Liu J; Sui J; Xiang X; Wang F; Chu L; Song S
Onco Targets Ther; 2016; 9():3485-92. PubMed ID: 27366085
[TBL] [Abstract][Full Text] [Related]
11. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
12. Relationship between PTEN gene expression and differentiation of human glioma.
Yang Y; Shao N; Luo G; Li L; Nilsson-Ehle P; Xu N
Scand J Clin Lab Invest; 2006; 66(6):469-75. PubMed ID: 17000554
[TBL] [Abstract][Full Text] [Related]
13. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells.
Li J; An G; Zhang M; Ma Q
Biochem Biophys Res Commun; 2016 Sep; 477(4):743-748. PubMed ID: 27363339
[TBL] [Abstract][Full Text] [Related]
15. Loss of Expression of PTEN is Associated with Worse Prognosis in Patients with Cancer.
Qiu ZX; Zhao S; Li L; Li WM
Asian Pac J Cancer Prev; 2015; 16(11):4691-8. PubMed ID: 26107225
[TBL] [Abstract][Full Text] [Related]
16. Mutation of PTEN in glioma stem/progenitor cells: a case report.
Zhao Y; Huang Q; Wang A; Dong J; Lan Q
Cancer Genet Cytogenet; 2009 Dec; 195(2):183-5. PubMed ID: 19963122
[No Abstract] [Full Text] [Related]
17. PTEN expression is associated with the outcome of lung cancer: evidence from a meta-analysis.
Gu J; Ou W; Huang L; Wu J; Li S; Xu J; Feng J; Liu B; Zhou Y
Minerva Med; 2016 Oct; 107(5):342-51. PubMed ID: 27333149
[TBL] [Abstract][Full Text] [Related]
18. Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
Stankovic T; Milinkovic V; Bankovic J; Dinic J; Tanic N; Dramicanin T; Tanic N
Biomed Pharmacother; 2014 Jun; 68(5):521-6. PubMed ID: 24767865
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis.
Tang L; Li X; Gao Y; Chen L; Gu L; Chen J; Lyu X; Zhang Y; Zhang X
PLoS One; 2017; 12(7):e0179437. PubMed ID: 28672019
[TBL] [Abstract][Full Text] [Related]
20. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
